SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as traders discuss its potential within the broader crypto market, with some pointing to Litecoin's security and utility for payments. Community members are debating its future prospects, with some anticipating a breakout and others remaining skeptical about its ability to maintain gains. The conversation includes discussion of potential price targets and the impact of broader market conditions.

🔥 COCK Token – The Ultimate Cross-Chain MemeFi Powerhouse 🔥  In just under 20 days, $COCK has smashed expectations, broken ATHs, and built a project that’s shaking up Cardano and the entire crypto space. 🐓 What Makes $COCK Special?      The Name: Love it or hate it, the energy and engagement it generates are undeniable. The nuance in language and wild appeal set us apart.     #MEMEFI Pioneer: We’re not just another meme coin. $COCK is leading a movement by combining DeFi mechanics, game theory, and community engagement into a groundbreaking ecosystem.     COCKARENA: At the core of our ecosystem is the COCKARENA, a PvP HODL game. Players battle it out, and early exit fees fuel redistributions, burns, and the treasury. This ensures price appreciation and long-term sustainability for loyal holders.  🎰 The COCK Casino  Our casino isn’t just fun—it’s a serious revenue stream for the FLOCK.      Games: Bonanza, Crash, Blackjack, and Roulette (coming soon!).     Impact: Over 7,834 ADA in profits generated within days, directly supporting rewards, burns, and reinvestment.  💰 COCK-ARENA Loans  Unlock liquidity without selling your tokens.      Loan Terms: Borrow up to 30% of your holdings while continuing to earn rewards in the arena.     Investor Focus: Perfect for savvy investors staying in the game while tapping into their holdings.  🤝 Our Insane Partnerships  We’re bridging gaps, building alliances, and breaking barriers across the crypto space. Key Partners:      DANZO: Powering #MEMEFI with Arena, Casino, and Loans.     KLENEK: Interactive training room.     HSKN (Charles Hoskilien): Supporting and starting COCKPIN with 115 AIR NODES for DePIN aggregation. Plans to add APEX and Earth Nodes through a crypto company incorporated in Costa Rica.     ELITE CATS / SNEKKIES / HOT / BANK: Rewarding NFT holders with COCK-LOCK tokens and vice versa.     OCKZ: COCKSOCKS, Golden Cock Ticket (1M COCK), airdrop rewards, and whitelist perks for holders of 200 ADA worth of $COCK.     OLI Partnership:         Content Creation: Lux and the team are crafting engaging educational content about memes and MemeFi for OLi's platform.         Strategic Investment: The OLi Community Trust will invest in $COCK, distributing 100% of rewards to $OLI holders.         Community Reach: Over 22,000 learners will discover $COCK through OLi's gamified ecosystem.     Hi-Rez the Rapper: Expanding reach in marketing and entertainment.     KUNO, CALEB, CADEN, FITY, ROVER, WhaleInsider: Influential collaborators driving crypto adoption and growth.     Cardano Girls: Helping us understand and communicate effectively with ADA’s female audience.     WallStreetBets: Breaking barriers and increasing engagement.     Antonio Brown: Endorsing, supporting, and even playing in the casino and arena!     Advisors:         BERIS, HECKTHESNEK, RTB, CRYPTOGENIUS: Trusted names advising and supporting the project.  Future Partnerships:  More collaborations are in the pipeline to continue expanding engagement and bring new eyes to ADA and CNTs. 🔥 Unmatched Results in Just 20 Days      Supply Burned: 1.65%, worth 148K ADA!     Arena Fees Collected: 54M COCK, worth over 500K ADA, fueling rewards, burns, and partnerships.     Staked COCK-LOCK: 11M COCK-LOCK in the liquid staking platform, with more coming.     Casino Revenue: Skyrocketing profits directly rewarding holders and growing the treasury.     Top Blast Contests: Generated over 120K ADA in volume, rewarding participants with over 50K ADA in prizes.  🌍 Our Vision  To be the most decentralized, rewarding, and innovative token on Cardano while fostering cross-chain collaboration and onboarding the masses.      Breaking Barriers: We’re bringing BTC, ETH, SOL, and other chains into the fold.     Community-Driven: Focused on building bridges and showcasing that crypto can be fun, rewarding, and sustainable.     Expansion: This is just the beginning. With more burns, rewards, and partnerships on the way, $COCK is set to redefine what’s possible in the MemeFi space.  💎 Time in the arena > Timing the market. The FLOCK is unstoppable. Let’s keep breaking walls for Cardano and onboard new users as we take $COCK to new heights.

CockCardano

CockCardano ($COCK) is trending as community members highlight its real-world utility through Cocky Wings LLC, a food trailer that generates revenue for token buybacks, and its partnership with Snek Energy. The community is actively discussing locking tokens in the Arena for passive income and attending Cocky Wings events. Overall, $COCK is seen as more than just a memecoin, with a strong community and consistent building.

P8BCI Is the CCM Creator Capital Markets Creator token created by Nick Wray, intended to form a community for talking about his journey with ALS, his experiences with Telepathy BCI experiments, as well as his experiences and journey through the Solana blockchain, and cryptocurrency world of Web 3. In addition to this, prior to his progression of ALS Nick was an avid drummer, a creative, and an enjoyer of philosophical discussion - and enabled now by his BCI explores creating, and in addition to sharing his story, interacting with the community forming around his experiences.

Telepath8

Telepath8 is trending as the community highlights developer Nick Wray, who they say built the project hands-free using Neuralink technology. Community members are pointing to apparent connections between Wray and Tesla/Elon Musk as a reason for increased interest. Social media links and a Telegram group are circulating as well.

NUM token is the native protocol token of Numbers Protocol. Numbers Protocol is building a Decentralized Photo Network for Web 3.0 For creating community, value, and trust in digital media.

Numbers Protocol

Numbers Protocol ($NUM) is trending as community members discuss its potential within the AI and DePIN sectors, highlighting its focus on building and utility. Despite a 'disgusting' chart, some investors see a good risk/reward ratio given its low market cap and potential for partnerships, pointing out it has key investors with YouTube and Twitch (Amazon). Some community members are calling for increased marketing efforts to raise awareness of the project.

Monero

Monero (XMR) is trending as discussions revolve around privacy, real-world usage, and its potential decoupling from Bitcoin. Community members highlight Monero's strong privacy features and some suggest it's undervalued, drawing comparisons to Bitcoin's early days. Others are discussing recent price action and technical analysis, with some anticipating a breakout.

Cheniere Energy, Inc. engages in liquefied natural gas (LNG) related businesses. It owns and operates LNG terminals, develops, constructs, and operates liquefaction projects near Corpus Christi, Texas, and at the Sabine Pass LNG terminal. The company was founded by Charif Souki in 1996 and is headquartered in Houston, TX.

Cheniere Energy Inc.

Cheniere Energy is trending as community members discuss the company's recent earnings and future prospects amid shifts in the LNG market. Factors driving interest include increased LNG tanker freight rates due to the approaching winter and tight vessel supply, as well as Europe's reliance on US LNG to meet gas inventory targets. Additionally, analysts are weighing in with updated ratings and price targets, contributing to the ongoing conversation.

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Vir Biotechnology Inc

Vir Biotechnology is trending as the community discusses the company's hepatitis delta program advancements, spotlighted at AASLD's The Liver Meeting, and looks forward to upcoming data from the SOLSTICE trial. Community members are focused on the potential for partnerships or licensing agreements driven by positive news. Despite some concerns around insider selling and sales of shares by Softbank, the overall sentiment leans towards optimism, fueled by the progress of the ECLIPSE program and potential catalysts in the hepatitis and oncology pipelines.

United States Commodity Funds LLC - United States Gasoline Fund LP

UGA is trending due to recent price strength and discussions around gasoline prices, with some analysts pointing towards a potential breakout. Community members are debating the impact of rising gasoline prices on inflation, consumer spending, and the broader economy. Traders are also monitoring potential opportunities around macro events, such as OPEC+ meetings.

ETF Series Solutions Trust - Point Bridge America First ETF

Point Bridge Gop Stock Tracker ETF

The Point Bridge GOP Stock Tracker ETF ($MAGA) is trending as community members discuss its performance in light of current political events and potential future impacts. Conversations revolve around the fund's alignment with Republican policies and figures like Trump, with some users suggesting it as a way to "Make America Great Again" through investments. Broader discussions include reactions to political news, economic policies, and the upcoming elections, all within the context of how they might affect the stock market and MAGA-related assets.

AIOZ Network is a DePIN for Web3 AI, Storage and Streaming.  AIOZ empowers a faster, secure and decentralized future.   Powered by a global network of DePINs,  AIOZ rewards you for sharing your computational resources for storing, transcoding, and streaming digital media content and powering decentralized AI computation.

AIOZ Network

AIOZ Network is trending amid community discussion around its potential within the AI crypto sector, with some drawing comparisons to previous altcoin season surges. Bullish sentiment points to potential growth catalysts, while others urge caution, citing bearish technical structures and potential pullbacks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib in Patients with NSCLC with EGFR mutations and Active Brain Metastases at the ESMO Congress 2025

Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib in Patients with NSCLC with EGFR mutations and Active Brain Metastases at the ESMO Congress 2025 Taiho Oncology and Cullinan...

BDTX vs. Cullinan Therapeutic: Which EGFR Challenger Is the Better Buy? 

BDTX and Cullinan advance next-gen EGFR inhibitors, but silevertinib's potential and valuation tilt momentum toward BDTX.

Shares of Cullinan Therapeutics Inc. fell in after-hours trading despite the company announcing a licensing agreement with Genrix Bio to develop velinotamig, a clinical-stage BCMA-directed bispecific T cell engager, for autoimmune diseases.The stock closed 1.2% higher at $9.07 on Tuesday before slipping 5.7% to $8.55 in after-hours trading.The deal grants Cullinan exclusive global rights, excluding Greater China, to velinotamig across all indications, with a $20 million upfront payment and potential milestone and royalty payments exceeding $692 million.&nbsp;The addition of velinotamig expands Cullinan’s autoimmune pipeline, alongside its CD19-targeting TCE, and is expected to support the company’s cash runway into 2028.Cullinan plans to leverage data from Genrix’s upcoming Phase 1 study in China to accelerate global development.&nbsp;CEO Nadim Ahmed said velinotamig could offer a “precise and potentially disease-modifying approach” by targeting self-reactive plasma cells implicated in certain autoimmune diseases.On Stocktwits, retail sentiment was ‘neutral’ amid ‘high’ message volume.The stock has declined 26.8% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Portrait of a doctor woman on the background of stock charts. | Image source: Getty Images

Cullinan Therapeutics Stock Slides After-Hours Despite $692M Autoimmune Drug Pact With Genrix

Cullinan Therapeutics secured global rights, excluding Greater China, to velinotamig from Genrix Bio, expanding its autoimmune pipeline with a second T cell engager. 

Equity

Taiho Pharmaceutical, Taiho Oncology, and Cullinan Therapeutics Announce Primary Endpoint Met in Phase 2b Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy

Taiho Pharmaceutical, Taiho Oncology, and Cullinan Therapeutics Announce Primary Endpoint Met in Phase 2b Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20...

UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were mostly higher, with the Dow Jones index gaining over 100 points on Tuesday.
read more...

Commit To Purchase Cullinan Oncology At $7.50, Earn 6.2% Annualized Using Options

Investors eyeing a purchase of Cullinan Oncology Inc (CGEM) stock, but tentative about paying the going market price of 17.15/share, might benefit from considering selling puts among the...

Cullinan Oncology (CGEM, $17.03) Aroon Indicator entered a Downtrend on March 28, 2024.

For the last three days, A.I.dvisor has detected that CGEM's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Cullinan Oncology (CGEM, $17.74) Aroon Indicator entered a Downtrend on March 27, 2024.

Cullinan Oncology (CGEM, $16.78) entered Downtrend as Momentum indicator drops below 0 level on Mar 26, 2024

This indicator may be signaling that CGEM's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Cullinan Oncology (CGEM, $15.5) Aroon Indicator entered a Downtrend on March 19, 2024.

Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

Cullinan Therapeutics Inc

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Current Price	$7.19
Prev Close	$7.35
Open	$7.24
Dividend Yield	0.00%
50-Day Moving Average	$7.05
Beta	1.09
Avg. Volume	1.45M
PE Ratio	-1.95

52-Week High	$17.50
52-Week Low	$5.68
Market Capitalization	$424.74M
EPS (Annual)	-$3.11
Price to Book	0.94
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

CGEM
Cullinan Oncology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CGEM News

CGEMCullinan Oncology Inc